Edit

About Us

We are here to create awareness on the vaccine through supply of T-shirt and Face cap to already vaccinated individuals in the Care Homes & Hospitals.

Our Aim and Objectives

  1. msjvjknvnvisvnsvsjv
  2. skvslkvjslvsjvsvjsvspo
  3. lsvsjjvsvjjsvosjvsp
  4. lskvjksvslkjvsjvos
  5. lkvvklvsnsb hshbusvhs
  6. vksnvjssnvvsvvksvjkslvs
  7. msvsljvsivijsiovs

Contact Us

Vaccinated & Proud!
Save Our NHS, Save Lives
& Stop The Spread
We are working together with Care Homes and Hospitals to supply T-Shirts, Badges and Face Caps to all vaccinated front-line workers and Care Homes residents across the UK. Donate now check SAVE OUR NHS & SAVE LIVES!

Vaccinated & Proud!
Save Our NHS, Save Lives
& Stop The Spread
We are working together with Care Homes and Hospitals to supply T-Shirts, Badges and Face Caps to all vaccinated front-line workers and Care Homes residents across the UK. Donate now check SAVE OUR NHS & SAVE LIVES!

Vaccinated & Proud!
Save Our NHS, Save Lives
& Stop The Spread
We are working together with Care Homes and Hospitals to supply T-Shirts, Badges and Face Caps to all vaccinated front-line workers and Care Homes residents across the UK. Donate now check SAVE OUR NHS & SAVE LIVES!

Vaccinated & Proud!
Save Our NHS, Save Lives
& Stop The Spread
We are working together with Care Homes and Hospitals to supply T-Shirts, Badges and Face Caps to all vaccinated front-line workers and Care Homes residents across the UK. Donate now check SAVE OUR NHS & SAVE LIVES!

Vaccinated & Proud!
Save Our NHS, Save Lives
& Stop The Spread
We are working together with Care Homes and Hospitals to supply T-Shirts, Badges and Face Caps to all vaccinated front-line workers and Care Homes residents across the UK. Donate now check SAVE OUR NHS & SAVE LIVES!

message

We are creating awareness on the vaccine

Know more about

All Political Parties Weclomes
the vaccine Approval

The United Kingdom on Wednesday 2nd December 2020 became the first country to approve a Covid-19 vaccine developed by Pfizer and its partner BioNTech.

Both the Pfizer/BioNTech and Moderna vaccines have been shown in large trials to reduce the risk of developing symptomatic Covid-19 infection by more than 90%.

“The regulator’s assessment that this is a safe and effective vaccine is a landmark moment, and an endorsement of the huge effort from a devoted international team of researchers and our dedicated trial participants. Though this is just the beginning, we will start to get ahead of the pandemic, protect health and economies when the vulnerable are vaccinated everywhere, as many as possible as soon possible.”

The decision to approve the vaccine was taken under Regulation 174 of the Human Medicine Regulations 2012, which enables rapid emergency regulatory approvals to address significant public health issues such as a pandemic. This is the first authorisation for this vaccine.

The MHRA’s decision was based on independent advice from its Commission on Human Medicines following a rolling review of trial data that included an interim analysis of the Phase III programme led by the University of Oxford. The data were also published in The Lancet on 8 December 2020.

Know more about

Our Free campaign shop

Donate

SUPPORT OUR CAMPAIGN

To Supply T-Shirts, Face Caps & Badges to Frontline Workers

Your donation will help us to supply Care Homes & Hospitals with T-shirts, Face Caps & Badges for those who had be vaccinated.

Vaccinated and Proud (VAP) is a national campaign to create awareness and encourage most of the population within the required age group to take the vaccine and stop the spread of the virus.

Know more about

Our mission & vision

Vaccines train our immune systems to create proteins that fight disease

COVID-19 Pfizer & Biontech vaccine

The final efficacy analysis from the trial also showed that the vaccine was 94% effective in adults over 65 seven days after the second dose was given, and that it worked equally well in people of all races and ethnicities. Although few people in the clinical trials went to the hospital or died, data suggest that people who got the Pfizer-BioNTech vaccine were less likely to have these more serious outcomes compared to people who got the saline placebo.

COVID-19 Moderna vaccine

Pfizer's and Moderna's vaccines could be programmed to fight cancer, heart disease and more, scientists say Both experimental vaccines had efficacy rates above 90 percent based on interim findings. Based on evidence from clinical trials, the Moderna vaccine was 94.1% effective at preventing laboratory-confirmed COVID-19 illness in people who received two doses who had no evidence of being previously infected.

COVID-19 Oxford & AstraZeneca vaccine

Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vaccine was highly effective in preventing COVID-19, the primary endpoint, and no hospitalisations or severe cases of the disease were reported in participants receiving the vaccine. AstraZeneca continues to engage with governments, multilateral organisations and collaborators around the world to ensure broad and equitable access to the vaccine at no profit for the duration of the pandemic.